Description |
The F box protein Skp2 (S-phase kinase-associated protein 2) is oncogenic, and its frequent amplification and overexpression correlate with the grade of malignancy of certain tumors. Skp2 controls p300-p53 signaling pathways in cancer cells, making it a potential molecular target for cancer therapy. This gene positively regulates the G(1)-S transition by controlling the stability of several G(1) regulators, such as the cell cycle inhibitor p27. This study provides evidence of a role for an F-box protein in oncogenesis and establishes SKP2 as a protooncogene causally involved in the pathogenesis of lymphomas.
|
Catalog Number
|
IW-PA1102 |
Quantity
|
9 ml |
Host
|
Rabbit
|
Clone
|
Polyclonal
|
Isotype
|
IgG
|
Immunogen
|
A synthetic peptide corresponding to a sequence at the N-terminal of human SKP2, different from the related rat and mouse sequence by three amino acids.
|
Purity
|
Immunogen affinity purified
|
Conjugate
|
Unconjugated
|
Species Reactivity
|
Human, mouse, rat.Not tested in other species. |
Positive Control
|
Human intestinal cancer, Hela cells.
|
Cellular Localization
|
Cytoplasmic/membrane
|
Form
|
Ready to use solution in PBS with stabilizer and 0.01% sodium azide. No further dilution needed. Serum blocking step should be omitted.
|
Storage
|
Store at 2-8 °C. Do not freeze.
|
Applications
|
IHC-P: Heat induced epitope retrieval enhance stain on formalin fixed paraffin sections. IHC-Fr: Not tested. ICC: Acetone fixed cells.
|
Limitations
|
This product is intended for Research Use Only. Interpretation of the test results is solely the responsibility of the user.
|
Precautions
|
Users should follow general laboratory precautions when handling this product. Wear personal protective equipment to avoid contact with skin and eyes.
|
References
|
|